Rein Therapeutics Secures $2.5 Million Unsecured Note Financing from Funicular Funds
I'm PortAI, I can summarize articles.
Rein Therapeutics Inc. has secured $2.5 million in unsecured note financing from Funicular Funds, LP. The agreement, signed on January 15, 2026, involves the issuance of a promissory note sold for $2 million, reflecting a 20% discount. The note matures upon Rein's next capital raise of at least $10 million or by June 30, 2026, with no interest payable beyond the discount. This transaction is exempt from SEC registration under Section 4(a)(2) and Rule 506 of Regulation D.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments